These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 10215961)

  • 1. Acute renal failure complicating high-dose intravenous immunoglobulin therapy for acquired haemophilia.
    McColl MD; Omran A; Walker ID; Lowe GD
    Haemophilia; 1999 Mar; 5(2):124-6. PubMed ID: 10215961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute renal failure after intravenous immunoglobulin therapy.
    Pasatiempo AM; Kroser JA; Rudnick M; Hoffman BI
    J Rheumatol; 1994 Feb; 21(2):347-9. PubMed ID: 8182648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous immunoglobulin induced-nephropathy: a complication of IVIG therapy.
    Ahsan N
    J Nephrol; 1998; 11(3):157-61. PubMed ID: 9650125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute renal failure in acquired haemophilia following the use of high dose intravenous immunoglobulin.
    Laidlaw S; Bainton R; Wilkie M; Makris M
    Haemophilia; 1999 Jul; 5(4):270-2. PubMed ID: 10469182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous gammglobulin-associated acute renal failure.
    Gupta N; Ahmed I; Nissel-Horowitz S; Patel D; Mehrotra B
    Am J Hematol; 2001 Feb; 66(2):151-2. PubMed ID: 11421298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary and renal toxicity of intravenous immunoglobulin.
    Rault R; Piraino B; Johnston JR; Oral A
    Clin Nephrol; 1991 Aug; 36(2):83-6. PubMed ID: 1934664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Acute renal failure following treatment with intravenously administered immunoglobulins].
    van Zanten AR; Beekhuyzen M; van der Meer YG; de Gooijer A; Feith GW
    Ned Tijdschr Geneeskd; 2003 Feb; 147(7):307-10. PubMed ID: 12622009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute renal failure after administration of intravenous immunoglobulin: review of the literature and case report.
    Winward DB; Brophy MT
    Pharmacotherapy; 1995; 15(6):765-72. PubMed ID: 8602385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety of intravenous immunoglobulin (IVIG) therapy.
    Katz U; Achiron A; Sherer Y; Shoenfeld Y
    Autoimmun Rev; 2007 Mar; 6(4):257-9. PubMed ID: 17317619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acquired inhibitor against factor IX in a child: successful treatment with high-dose immunoglobulin and dexamethasone.
    Mazzucconi MG; Peraino M; Bizzoni L; Bernasconi S; Luciani M; Rossi GD
    Haemophilia; 1999 Mar; 5(2):132-4. PubMed ID: 10215963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute renal failure, translocational hyponatremia and hyperkalemia following intravenous immunoglobulin therapy.
    Daphnis E; Stylianou K; Alexandrakis M; Xylouri I; Vardaki E; Stratigis S; Kyriazis J
    Nephron Clin Pract; 2007; 106(4):c143-8. PubMed ID: 17596722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impairment of renal function after intravenous immunoglobulin.
    Soares SM; Sethi S
    Nephrol Dial Transplant; 2006 Mar; 21(3):816-7. PubMed ID: 16399766
    [No Abstract]   [Full Text] [Related]  

  • 13. Reemergence of sucrose nephropathy: acute renal failure caused by high-dose intravenous immune globulin therapy.
    Zhang R; Szerlip HM
    South Med J; 2000 Sep; 93(9):901-4. PubMed ID: 11005352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute renal failure resulting from intravenous immunoglobulin therapy.
    Wajanaponsan N; Cheng SF
    Hawaii Med J; 2004 Sep; 63(9):266-7. PubMed ID: 15540524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal failure and intravenous immunoglobulin.
    Phillips AO
    Clin Nephrol; 1992 Apr; 37(4):217. PubMed ID: 1582064
    [No Abstract]   [Full Text] [Related]  

  • 16. Acute renal failure in a pediatric kidney allograft recipient treated with intravenous immunoglobulin for parvovirus B19 induced pure red cell aplasia.
    Subtirelu MM; Flynn JT; Schechner RS; Pullman JM; Feuerstein D; Del Rio M
    Pediatr Transplant; 2005 Dec; 9(6):801-4. PubMed ID: 16269055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute anuric renal failure secondary to intravenous immunoglobulin in diabetic nephropathy.
    Biswas M; Evans PJ
    Diabetes Res Clin Pract; 2007 Apr; 76(1):139-41. PubMed ID: 16959362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The modified Bonn Malmö protocol (MBMP) in the treatment of acquired haemophilia A].
    Zeitler H; Ulrich-Merzenich G; Walger P; Düsing R; Vetter H; Brackmann HH
    Dtsch Med Wochenschr; 2006 Jan; 131(4):141-7. PubMed ID: 16429335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful immune tolerance induction with high-dose coagulation factor VIII and intravenous immunoglobulins in a patient with congenital hemophilia and high-titer inhibitor of coagulation factor VIII despite unfavorable prognosis for the therapy.
    Kubisz P; Plamenová I; Hollý P; Stasko J
    Med Sci Monit; 2009 Jun; 15(6):CS105-11. PubMed ID: 19488019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High response to intravenous immunoglobulin in the treatment of acquired hemophilia in an elderly patient.
    Paccalin M; Forestier D; Poupet JY; Roy-Peaud F; Roblot P; Becq-Giraudon B; Boinot C
    J Am Geriatr Soc; 2004 Jul; 52(7):1222-3. PubMed ID: 15209674
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.